en
E-mail us
+1-609-604-8303
bd_global@crystalpharmatech.com
 cn
cn
Knowledge Hub Explore
Holistic Polymorph Screening - Identify the Lead Crystal Form and Accelerate CMC Progress Whitepaper Holistic Polymorph Screening - Identify the Lead Crystal Form and Accelerate CMC Progress
Holistic Polymorph Screening - Identify the Lead Crystal Form and Accelerate CMC Progress Technical Articles Holistic Polymorph Screening - Identify the Lead Crystal Form and Accelerate CMC Progress
Mol2Med™ Developability Assessment: Material-Sparing, Rapid Studies, and Developability Strategies Technical Articles Mol2Med™ Developability Assessment: Material-Sparing, Rapid Studies, and Developability Strategies
Webinar Series Explore
Solid Form Landscape to Formulation Strategy: The Role of Computational Screening and Risk Assessment Crystal Pharmatech Formulation Forum Solid Form Landscape to Formulation Strategy: The Role of Computational Screening and Risk Assessment
Applying PBPK and PBBM Across R&D: From Early Insights to Formulation Crystal Pharmatech Formulation Forum Applying PBPK and PBBM Across R&D: From Early Insights to Formulation
Patient-Centered Controlled and Modified Release Drug Delivery: Formulation & Process Development Crystal Pharmatech Formulation Forum Patient-Centered Controlled and Modified Release Drug Delivery: Formulation & Process Development
Events Explore
Join Crystal Pharmatech and SCX CMC Solutions at our New Jersey Facility for the live Crystal Classroom - Hands-on Training with API Form Selection Instrumentation
Events
Join Crystal Pharmatech and SCX CMC Solutions at our New Jersey Facility for the live Crystal Classroom - Hands-on Training with API Form Selection Instrumentation
January 15, 2026
AAPS PharmSci 360
November 9–12, 2025
CPHI Frankfurt 2025
October 28-30, 2025
Discovery & Development US 2025
October 2-3, 2025
News Explore
Crystal Pharmatech Receives CNAS Reaccreditation, Scope Expansion, and Address Approval
News
Crystal Pharmatech Receives CNAS Reaccreditation, Scope Expansion, and Address Approval
11 Aug 2025
Crystal Pharmatech and Divamics Announce Strategic Collaboration to Accelerate Drug Development through AI, Crystal Form, and Formulation Innovation
09 May 2025
Improving the Manufacture of mRNA Biologics
13 Nov 2024
Crystal Bio Appoints Dr. Ye Gu as Co-founder, CTO, and Head of USA BD
14 May 2024
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics CMC Analytical Services Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Technology
Quick Links
About Us Events
Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512
2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512
CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123
Sitemap
Privacy Policy
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics CMC Analytical Services Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Technology
Quick Links
About Us Events
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512
2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512
CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
bd_global@crystalpharmatech.com +1-609-604-8303
Sitemap
Privacy Policy
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. Part of the tracking is necessary to ensure SEO effectiveness,
By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.
Reject Accept